Evidence map›Paper›PMID 41381696›Full record

SynthesisScientific reports2025

Performance and challenges of malaria rapid diagnostic tests in endemic regions of Africa.

Fiyinfoluwa Demilade Ojeniyi, Adeola Oluwakemi Ayoola, Olajumoke Ibitoye, Oluyinka Oladele Opaleye, Olugbenga Adekunle Olowe, Leonard Ona Ehigie, Bolaji N Thomas, Olusola Ojurongbe

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Detection ofASM case reports · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Heme oxygenase-1 and malaria pathogenesis.Frontiers in immunology · 2026
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fiyinfoluwa Demilade OjeniyiCenter for Emerging and Re-emerging Infectious Diseases, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Adeola Oluwakemi AyoolaCenter for Emerging and Re-emerging Infectious Diseases, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Olajumoke IbitoyeDepartment of Computer and Information Sciences, Covenant University, Ota, Nigeria.
Oluyinka Oladele OpaleyeCenter for Emerging and Re-emerging Infectious Diseases, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Olugbenga Adekunle OloweCenter for Emerging and Re-emerging Infectious Diseases, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Leonard Ona EhigieDepartment of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Bolaji N ThomasDepartment of Biomedical Sciences, College of Health Sciences and Technology, Rochester Institute of Technology, Rochester, NY, 14623, USA.
Olusola OjurongbeCenter for Emerging and Re-emerging Infectious Diseases, Ladoke Akintola University of Technology, Ogbomoso, Nigeria. oojurongbe@lautech.edu.ng.

Funding

Alexander von Humboldt-Stiftung Humboldt Research Hubs in Africa' financed by the Bayer Science Foundation
6 · The paper itself

Abstract

Rapid diagnostic tests (RDTs) have revolutionized malaria diagnosis, playing a crucial role in improving timely treatment and supporting surveillance efforts, especially in resource-limited settings. However, the performance of RDTs can vary widely due to factors such as parasite genetic diversity, environmental conditions, and operational challenges. Understanding these variations is essential to ensuring accurate and reliable malaria diagnosis. This systematic review and meta-analysis critically evaluate the diagnostic performance of malaria RDTs across sub-Saharan Africa, identifying key gaps and proposing strategies for developing novel tests. By pooling data from 48 studies, the analysis quantifies the sensitivity and specificity of various RDT brands in different settings. The results reveal considerable variability, influenced by factors such as antigen persistence, cross-reactivity with other infections, and genetic polymorphism in the HRP2 gene, which can lead to false positives and negatives. The findings underscore the need for region-specific diagnostic strategies and the development of advanced diagnostic tools capable of detecting low-level parasitemia and differentiating between Plasmodium species. Emerging technologies and multi-platform approaches are recommended to enhance the accuracy and reliability of malaria diagnosis, ultimately contributing to more effective malaria control and elimination efforts in sub-Saharan Africa.

Indexed as

Diagnostic Tests, RoutineMalariaAfricaAfrica South of the SaharaAntigens, ProtozoanEndemic DiseasesHumansPlasmodium falciparumProtozoan ProteinsRapid Diagnostic TestsSensitivity and SpecificityAntigens, ProtozoanProtozoan ProteinsDiagnostic performanceHRP2 geneMalariaMeta-analysisRapid diagnostic tests (RDTs)SensitivitySpecificitySub-Saharan Africa

Identifiers

PMID41381696
PMCPMC12701009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.